Browse the corpus

REFERENCES Kurtz I. Molecular pathogenesis of Bartter's and Gitelman's syndromes. Kidney Int 1998; 54:1396. Stein JH. The pathogenetic spectrum of Bartter's syndrome. Kidney Int 1985; 28:85. Simon DB, Karet FE, Hamdan JM, et al. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 1996; 13:183. Simon DB, Karet FE, Rodriguez-Soriano J, et al. Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet 1996; 14:152. Simon DB, Nelson-Williams C, Bia MJ, et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 1996; 12:24. Ji W, Foo JN, O'Roak BJ, et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 2008; 40:592. Gladziwa U, Schwarz R, Gitter AH, et al. Chronic hypokalaemia of adults: Gitelman's syndrome is frequent but classical Bartter's syndrome is rare. Nephrol Dial Transplant 1995; 10:1607. Konrad M, Weber S. Recent advances in molecular genetics of hereditary magnesium-losing disorders. J Am Soc Nephrol 2003; 14:249. Monnens L, Bindels R, Grünfeld JP. Gitelman syndrome comes of age. Nephrol Dial Transplant 1998; 13:1617. Gill JR Jr, Bartter FC. Evidence for a prostaglandin-independent defect in chloride reabsorption in the loop of Henle as a proximal cause of Bartter's syncrome. Am J Med 1978; 65:766. Uribarri J, Alveranga D, Oh MS, et al. Bartter's syndrome due to a defect in salt reabsorption in the distal convoluted tubule. Nephron 1985; 40:52. Bettinelli A, Bianchetti MG, Girardin E, et al. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr 1992; 120:38. Vaisbich MH, Fujimura MD, Koch VH. Bartter syndrome: benefits and side effects of long-term treatment. Pediatr Nephrol 2004; 19:858. Dillon MJ, Shah V, Mitchell MD. Bartter's syndrome: 10 cases in childhood. Results of long-term indomethacin therapy. Q J Med 1979; 48:429. Sann L, David L, Bernheim J, François R. Hypophosphatemia and hyperparathyroidism in a case of Bartter's syndrome. Helv Paediatr Acta 1978; 33:299. Gamba G. Molecular biology of distal nephron sodium transport mechanisms. Kidney Int 1999; 56:1606.

Dillon MJ, Shah V, Mitchell MD. Bartter's syndrome: 10 cases in childhood. Results of long-term indomethacin therapy. Q J Med 1979; 48:429. Sann L, David L, Bernheim J, François R. Hypophosphatemia and hyperparathyroidism in a case of Bartter's syndrome. Helv Paediatr Acta 1978; 33:299. Gamba G. Molecular biology of distal nephron sodium transport mechanisms. Kidney Int 1999; 56:1606. Waldegger S, Jentsch TJ. From tonus to tonicity: physiology of CLC chloride channels. J Am Soc Nephrol 2000; 11:1331. Lorenz JN, Baird NR, Judd LM, et al. Impaired renal NaCl absorption in mice lacking the ROMK potassium channel, a model for type II Bartter's syndrome. J Biol Chem 2002; 277:37871. Simon DB, Bindra RS, Mansfield TA, et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 1997; 17:171. Konrad M, Vollmer M, Lemmink HH, et al. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol 2000; 11:1449. Zelikovic I. Hypokalaemic salt-losing tubulopathies: an evolving story. Nephrol Dial Transplant 2003; 18:1696. Seyberth HW. An improved terminology and classification of Bartter-like syndromes. Nat Clin Pract Nephrol 2008; 4:560. Nozu K, Iijima K, Kanda K, et al. The pharmacological characteristics of molecular-based inherited salt-losing tubulopathies. J Clin Endocrinol Metab 2010; 95:E511. Bettinelli A, Borsa N, Bellantuono R, et al. Patients with biallelic mutations in the chloride channel gene CLCNKB: long-term management and outcome. Am J Kidney Dis 2007; 49:91. Birkenhäger R, Otto E, Schürmann MJ, et al. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet 2001; 29:310. Estévez R, Boettger T, Stein V, et al. Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion. Nature 2001; 414:558. Izzedine H, Tankere F, Launay-Vacher V, Deray G. Ear and kidney syndromes: molecular versus clinical approach. Kidney Int 2004; 65:369. Kobayashi K, Uchida S, Okamura HO, et al. Human CLC-KB gene promoter drives the EGFP expression in the specific distal nephron segments and inner ear. J Am Soc Nephrol 2002; 13:1992. Janssen AG, Scholl U, Domeyer C, et al. Disease-causing dysfunctions of barttin in Bartter syndrome type IV. J Am Soc Nephrol 2009; 20:145.

Izzedine H, Tankere F, Launay-Vacher V, Deray G. Ear and kidney syndromes: molecular versus clinical approach. Kidney Int 2004; 65:369. Kobayashi K, Uchida S, Okamura HO, et al. Human CLC-KB gene promoter drives the EGFP expression in the specific distal nephron segments and inner ear. J Am Soc Nephrol 2002; 13:1992. Janssen AG, Scholl U, Domeyer C, et al. Disease-causing dysfunctions of barttin in Bartter syndrome type IV. J Am Soc Nephrol 2009; 20:145. Schlingmann KP, Konrad M, Jeck N, et al. Salt wasting and deafness resulting from mutations in two chloride channels. N Engl J Med 2004; 350:1314. Hebert SC. Extracellular calcium-sensing receptor: implications for calcium and magnesium handling in the kidney. Kidney Int 1996; 50:2129. Watanabe S, Fukumoto S, Chang H, et al. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 2002; 360:692. Wang WH, Lu M, Hebert SC. Cytochrome P-450 metabolites mediate extracellular Ca(2+)-induced inhibition of apical K+ channels in the TAL. Am J Physiol 1996; 271:C103. Jentsch TJ. Chloride transport in the kidney: lessons from human disease and knockout mice. J Am Soc Nephrol 2005; 16:1549. Pressler CA, Heinzinger J, Jeck N, et al. Late-onset manifestation of antenatal Bartter syndrome as a result of residual function of the mutated renal Na+-K+-2Cl- co-transporter. J Am Soc Nephrol 2006; 17:2136. Bockenhauer D, Feather S, Stanescu HC, et al. Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med 2009; 360:1960. Chou CL, Chen YH, Chau T, Lin SH. Acquired bartter-like syndrome associated with gentamicin administration. Am J Med Sci 2005; 329:144. Chen YS, Fang HC, Chou KJ, et al. Gentamicin-induced Bartter-like syndrome. Am J Kidney Dis 2009; 54:1158. Chrispal A, Boorugu H, Prabhakar AT, Moses V. Amikacin-induced type 5 Bartter-like syndrome with severe hypocalcemia. J Postgrad Med 2009; 55:208. Zietse R, Zoutendijk R, Hoorn EJ. Fluid, electrolyte and acid-base disorders associated with antibiotic therapy. Nat Rev Nephrol 2009; 5:193. Cruz DN, Shaer AJ, Bia MJ, et al. Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int 2001; 59:710. Cruz DN, Simon DB, Nelson-Williams C, et al. Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension 2001; 37:1458.

Zietse R, Zoutendijk R, Hoorn EJ. Fluid, electrolyte and acid-base disorders associated with antibiotic therapy. Nat Rev Nephrol 2009; 5:193. Cruz DN, Shaer AJ, Bia MJ, et al. Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int 2001; 59:710. Cruz DN, Simon DB, Nelson-Williams C, et al. Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension 2001; 37:1458. Tammaro F, Bettinelli A, Cattarelli D, et al. Early appearance of hypokalemia in Gitelman syndrome. Pediatr Nephrol 2010; 25:2179. Ea HK, Blanchard A, Dougados M, Roux C. Chondrocalcinosis secondary to hypomagnesemia in Gitelman's syndrome. J Rheumatol 2005; 32:1840. Riveira-Munoz E, Chang Q, Godefroid N, et al. Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome. J Am Soc Nephrol 2007; 18:1271. De Jong JC, Van Der Vliet WA, Van Den Heuvel LP, et al. Functional expression of mutations in the human NaCl cotransporter: evidence for impaired routing mechanisms in Gitelman's syndrome. J Am Soc Nephrol 2002; 13:1442. Vargas-Poussou R, Dahan K, Kahila D, et al. Spectrum of mutations in Gitelman syndrome. J Am Soc Nephrol 2011; 22:693. Lin SH, Cheng NL, Hsu YJ, Halperin ML. Intrafamilial phenotype variability in patients with Gitelman syndrome having the same mutations in their thiazide-sensitive sodium/chloride cotransporter. Am J Kidney Dis 2004; 43:304. Zelikovic I, Szargel R, Hawash A, et al. A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes. Kidney Int 2003; 63:24. Jeck N, Konrad M, Peters M, et al. Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr Res 2000; 48:754. Kömhoff M, Reinalter SC, Gröne HJ, Seyberth HW. Induction of microsomal prostaglandin E2 synthase in the macula densa in children with hypokalemic salt-losing tubulopathies. Pediatr Res 2004; 55:261. Fujita T, Ando K, Sato Y, et al. Independent roles of prostaglandins and the renin-angiotensin system in abnormal vascular reactivity in Bartter's syndrome. Am J Med 1982; 73:71. Ciabattoni G, Pugliese F, Cinotti GA, et al. Characterization of furosemide-induced activation of the renal prostaglandin system. Eur J Pharmacol 1979; 60:181.

Fujita T, Ando K, Sato Y, et al. Independent roles of prostaglandins and the renin-angiotensin system in abnormal vascular reactivity in Bartter's syndrome. Am J Med 1982; 73:71. Ciabattoni G, Pugliese F, Cinotti GA, et al. Characterization of furosemide-induced activation of the renal prostaglandin system. Eur J Pharmacol 1979; 60:181. Friis UG, Stubbe J, Uhrenholt TR, et al. Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells. Am J Physiol Renal Physiol 2005; 289:F989. Jensen BL, Schmid C, Kurtz A. Prostaglandins stimulate renin secretion and renin mRNA in mouse renal juxtaglomerular cells. Am J Physiol 1996; 271:F659. Lüthy C, Bettinelli A, Iselin S, et al. Normal prostaglandinuria E2 in Gitelman's syndrome, the hypocalciuric variant of Bartter's syndrome. Am J Kidney Dis 1995; 25:824. Patak RV, Fadem SZ, Rosenblatt SG, et al. Diuretic-induced changes in renal blood flow and prostaglandin E excretion in the dog. Am J Physiol 1979; 236:F494. Miyanoshita A, Terada M, Endou H. Furosemide directly stimulates prostaglandin E2 production in the thick ascending limb of Henle's loop. J Pharmacol Exp Ther 1989; 251:1155. Liguori A, Casini A, Di Loreto M, et al. Loop diuretics enhance the secretion of prostacyclin in vitro, in healthy persons, and in patients with chronic heart failure. Eur J Clin Pharmacol 1999; 55:117. Takahashi N, Brooks HL, Wade JB, et al. Posttranscriptional compensation for heterozygous disruption of the kidney-specific NaK2Cl cotransporter gene. J Am Soc Nephrol 2002; 13:604. Peters M, Jeck N, Reinalter S, et al. Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med 2002; 112:183. Ring T, Knoers N, Oh MS, Halperin ML. Reevaluation of the criteria for the clinical diagnosis of Gitelman syndrome. Pediatr Nephrol 2002; 17:612. Bianchetti MG, Edefonti A, Bettinelli A. The biochemical diagnosis of Gitelman disease and the definition of "hypocalciuria". Pediatr Nephrol 2003; 18:409. Veldhuis JD, Bardin CW, Demers LM. Metabolic mimicry of Bartter's syndrome by covert vomiting: utility of urinary chloride determinations. Am J Med 1979; 66:361. Mitchell JE, Seim HC, Colon E, Pomeroy C. Medical complications and medical management of bulimia. Ann Intern Med 1987; 107:71.

Bianchetti MG, Edefonti A, Bettinelli A. The biochemical diagnosis of Gitelman disease and the definition of "hypocalciuria". Pediatr Nephrol 2003; 18:409. Veldhuis JD, Bardin CW, Demers LM. Metabolic mimicry of Bartter's syndrome by covert vomiting: utility of urinary chloride determinations. Am J Med 1979; 66:361. Mitchell JE, Seim HC, Colon E, Pomeroy C. Medical complications and medical management of bulimia. Ann Intern Med 1987; 107:71. Sherman RA, Eisinger RP. The use (and misuse) of urinary sodium and chloride measurements. JAMA 1982; 247:3121. Kassirer JP, Schwartz WB. The response of normal man to selective depletion of hydrochloric acid. Factors in the genesis of persistent gastric alkalosis. Am J Med 1966; 40:10. Jamison RL, Ross JC, Kempson RL, et al. Surreptitious diuretic ingestion and pseudo-Bartter's syndrome. Am J Med 1982; 73:142. Colussi G, Rombolà G, Airaghi C, et al. Pseudo-Bartter's syndrome from surreptitious diuretic intake: differential diagnosis with true Bartter's syndrome. Nephrol Dial Transplant 1992; 7:896. Sasaki H, Kawasaki T, Yamamoto T, et al. [Pseudo-Bartter's syndrome induced by surreptitious ingestion of furosemide to lose weight: a case report and possible pathophysiology]. Nihon Naibunpi Gakkai Zasshi 1986; 62:867. D'Avanzo M, Santinelli R, Tolone C, et al. Concealed administration of frusemide simulating Bartter syndrome in a 4.5-year-old boy. Pediatr Nephrol 1995; 9:749. Lukie BE, Wright CJ. The room search. J Clin Gastroenterol 1984; 6:553. Plumeri PA. The room search. J Clin Gastroenterol 1984; 6:181. Kose M, Pekcan S, Ozcelik U, et al. An epidemic of pseudo-Bartter syndrome in cystic fibrosis patients. Eur J Pediatr 2008; 167:115. Kennedy JD, Dinwiddie R, Daman-Willems C, et al. Pseudo-Bartter's syndrome in cystic fibrosis. Arch Dis Child 1990; 65:786. Escobar Castro H, Medina E, Kirchschläger E, et al. Metabolic alkalosis with hypo-electrolytaemia or pseudo-Bartter syndrome as a presentation of cystic fibrosis in infancy. Discription of three cases. Eur J Pediatr 1995; 154:868. Roy S 3rd, Arant BS Jr. Hypokalemic metabolic alkalosis in normotensive infants with elevated plasma renin activity and hyperaldosteronism: role of dietary chloride deficiency. Pediatrics 1981; 67:423. Linshaw MA, Harrison HL, Gruskin AB, et al. Hypochloremic alkalosis in infants associated with soy protein formula. J Pediatr 1980; 96:635.

Roy S 3rd, Arant BS Jr. Hypokalemic metabolic alkalosis in normotensive infants with elevated plasma renin activity and hyperaldosteronism: role of dietary chloride deficiency. Pediatrics 1981; 67:423. Linshaw MA, Harrison HL, Gruskin AB, et al. Hypochloremic alkalosis in infants associated with soy protein formula. J Pediatr 1980; 96:635. Malloy MH, Graubard B, Moss H, et al. Hypochloremic metabolic alkalosis from ingestion of a chloride-deficient infant formula: outcome 9 and 10 years later. Pediatrics 1991; 87:811. Reznik VM, Griswold WR, Mendoza SA, McNeal RM. Neo-Mull-Soy metabolic alkalosis: a model of Bartter's syndrome? Pediatrics 1980; 66:784. Panichpisal K, Angulo-Pernett F, Selhi S, Nugent KM. Gitelman-like syndrome after cisplatin therapy: a case report and literature review. BMC Nephrol 2006; 7:10. Kim YK, Song HC, Kim WY, et al. Acquired Gitelman syndrome in a patient with primary Sjögren syndrome. Am J Kidney Dis 2008; 52:1163. Colussi G, Bettinelli A, Tedeschi S, et al. A thiazide test for the diagnosis of renal tubular hypokalemic disorders. Clin J Am Soc Nephrol 2007; 2:454. Puschett JB, Greenberg A, Mitro R, et al. Variant of Bartter's syndrome with a distal tubular rather than loop of Henle defect. Nephron 1988; 50:205. Sutton RA, Mavichak V, Halabe A, Wilkins GE. Bartter's syndrome: evidence suggesting a distal tubular defect in a hypocalciuric variant of the syndrome. Miner Electrolyte Metab 1992; 18:43. Colussi G, Rombolà G, Brunati C, De Ferrari ME. Abnormal reabsorption of Na+/CI- by the thiazide-inhibitable transporter of the distal convoluted tubule in Gitelman's syndrome. Am J Nephrol 1997; 17:103. Bettinelli A, Vezzoli G, Colussi G, et al. Genotype-phenotype correlations in normotensive patients with primary renal tubular hypokalemic metabolic alkalosis. J Nephrol 1998; 11:61. Kageyama K, Terui K, Shoji M, et al. Diagnosis of a case of Gitelman's syndrome based on renal clearance studies and gene analysis of a novel mutation of the thiazide-sensitive Na-Cl cotransporter. J Endocrinol Invest 2005; 28:822. Proesmans W, Massa G, Vandenberghe K, Van Assche A. Prenatal diagnosis of Bartter syndrome. Lancet 1987; 1:394. Proesmans W. Threading through the mizmaze of Bartter syndrome. Pediatr Nephrol 2006; 21:896. Tourne G, Collet F, Varlet MN, et al. [Prenatal Bartter's syndrome. Report of two cases]. J Gynecol Obstet Biol Reprod (Paris) 2003; 32:751.

Proesmans W, Massa G, Vandenberghe K, Van Assche A. Prenatal diagnosis of Bartter syndrome. Lancet 1987; 1:394. Proesmans W. Threading through the mizmaze of Bartter syndrome. Pediatr Nephrol 2006; 21:896. Tourne G, Collet F, Varlet MN, et al. [Prenatal Bartter's syndrome. Report of two cases]. J Gynecol Obstet Biol Reprod (Paris) 2003; 32:751. Vinci JM, Gill JR Jr, Bowden RE, et al. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition. J Clin Invest 1978; 61:1671. Griffing GT, Komanicky P, Aurecchia SA, et al. Amiloride in Bartter's syndrome. Clin Pharmacol Ther 1982; 31:713. Colussi G, Rombolà G, De Ferrari ME, et al. Correction of hypokalemia with antialdosterone therapy in Gitelman's syndrome. Am J Nephrol 1994; 14:127. Hené RJ, Koomans HA, Dorhout Mees EJ, et al. Correction of hypokalemia in Bartter's syndrome by enalapril. Am J Kidney Dis 1987; 9:200. Morales JM, Ruilope LM, Praga M, et al. Long-term enalapril therapy in Bartter's syndrome. Nephron 1988; 48:327. Mizuno K, Yamazaki M, Fukuchi S. Hypotensive response to angiotensin I-converting enzyme inhibitor in Bartter's syndrome. N Engl J Med 1979; 300:1057. Calò LA, Marchini F, Davis PA, et al. Kidney transplant in Gitelman's syndrome. Report of the first case. J Nephrol 2003; 16:144. Kim JY, Kim GA, Song JH, et al. A case of living-related kidney transplantation in Bartter's syndrome. Yonsei Med J 2000; 41:662. Takahashi M, Yanagida N, Okano M, et al. A first report: living related kidney transplantation on a patient with Bartter's syndrome. Transplant Proc 1996; 28:1588. Chaudhuri A, Salvatierra O Jr, Alexander SR, Sarwal MM. Option of pre-emptive nephrectomy and renal transplantation for Bartter's syndrome. Pediatr Transplant 2006; 10:266. de Jong JC, Willems PH, Goossens M, et al. Effects of chemical chaperones on partially retarded NaCl cotransporter mutants associated with Gitelman's syndrome in a mouse cortical collecting duct cell line. Nephrol Dial Transplant 2004; 19:1069. Peters M, Ermert S, Jeck N, et al. Classification and rescue of ROMK mutations underlying hyperprostaglandin E syndrome/antenatal Bartter syndrome. Kidney Int 2003; 64:923. Topic 2344 Version 12.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0504-125.39.66.147-782CD78CC9-S244013.14]